Delivery Order SPE2DB22D1017-SPE2DB25FF4BU
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$6.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 5% patches. The firm-fixed-price contract has a ceiling value of $6,305.30 and a period of performance through January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with an award value of $6,897.00, is for the delivery of Lidocaine 5% Patches over a period ending on March 7, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% patches. The contract has a ceiling value of $3,595.00 and a completion date of September 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract has a ceiling value of $3,689.07 and a period of performance through May 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,001.46, is for the delivery of Lidocaine 5% patches over a period ending on September 4, 2024. The contract is a Delivery Order under a Firm Fixed Price structure, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,518.86 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches. The contract has a period of performance through December 17, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Lidocaine 5% Patch 30S. The contract, which is not set aside, has a ceiling value of $7,131.04 and an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This federal contract award, identified as SPE2DB22D3004|SPE2DB25FPH90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of Lidocaine 5% Patches, a medical product used for pain management. The contract has a ceiling value of $1,164.78 and an ultimate completion date of January 31, 2025. AmerisourceBergen holds a...
This contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% patches, a type of prescription medication. The contract has a ceiling value of $5,888.70 and an ultimate completion date of June 25, 2024. It is a firm-fixed-price delivery order contract, meaning Amerisourcebergen will be paid a pre-determined amount for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,351.70 and is for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...